CD40 function in squamous cell cancer of the head and neck

16Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

CD40 is expressed on basal keratinocytes and Squamous Cell Cancer of the Head and Neck (SCCHN) tumor cells in vivo and in vitro. CD40 ligation reduces proliferation of SCCHN cell lines and enhances EGFr mediated inhibition of proliferation. We investigated the mechanisms of CD40 function and EGFr cross-communication in SCCHN cell lines. CD40 ligation inhibited spontaneous and Fas-induced apoptosis. CD40 ligation specifically increased the secretion of IL-8, VEGF and PGE2 but not IL-6, IL-10, FasL, GM-CSF, or TGFα. Co-ligation with EGFr further increased IL-8, VEGF and PGE2 secretion. CD40 ligation also induced delayed activation and tyrosine phosphorylation of EGFr. CD40 induces secretion of specific proinflammatory and proangiogenic cytokines, inhibits spontaneous and Fas-induced apoptosis and increases EGFr phosphorylation. CD40 signaling may enhance the survival of SCCHN and tumor stroma. © 2004 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Cao, W., Cavacini, L. A., Tillman, K. C., & Posner, M. R. (2005). CD40 function in squamous cell cancer of the head and neck. Oral Oncology, 41(5), 462–469. https://doi.org/10.1016/j.oraloncology.2004.11.005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free